• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR Back to Search Results
Model Number NEUROSTAR ADVANCED THERAPY 3.0
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Head Injury (1879); Hearing Impairment (1881); Nausea (1970); Vertigo (2134); Sleep Dysfunction (2517); Skin Inflammation/ Irritation (4545)
Event Date 01/30/2023
Event Type  Injury  
Manufacturer Narrative
The tms provider could not be reached to provide additional information and therefore a full investigation coud not be completed.
 
Event Description
Neuronetics received a patient reported medwatch (mw5115632) from fda alleging that the patient had adverse reactions from 20-30 tms therapy treatments including headaches, sleep interuptions, scalp irritation, vertigo, nausea and eardrum twitching that affects hearing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROSTAR ADVANCED THERAPY
Type of Device
TRANSCRANIAL MAGNETIC STIMULATOR
Manufacturer (Section D)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer (Section G)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer Contact
robin fatzinger
3222 phoenixville pike
malvern, PA 19355
6109814027
MDR Report Key16771069
MDR Text Key313599104
Report Number3004824012-2023-00009
Device Sequence Number1
Product Code OBP
UDI-Device Identifier00869378000117
UDI-Public00869378000117
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K161519
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 04/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEUROSTAR ADVANCED THERAPY 3.0
Device Catalogue Number81-02315-000
Was Device Available for Evaluation? No
Date Manufacturer Received03/20/2023
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
BUSPIRONE.; EXCEDRINE FOR HEADACHES.; PRISTIQ.; TOPIRAMATE (PRESCRIBED FOR VERTIGO).
Patient Outcome(s) Other;
Patient Age31 YR
Patient SexFemale
Patient Weight67 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-